Literature DB >> 2822925

The impact of protein size and charge on its retention in articular cartilage.

P L van Lent1, W B van den Berg, J Schalkwijk, L B van de Putte, L van den Bersselaar.   

Abstract

The interaction of several globular proteins with intact murine hyaline articular cartilage was studied in vitro. Proteins with molecular weights from 12 to 440 kDa and isoelectric points (pI) from 4.5 to 10 were tested for the ability to penetrate and persist in cartilage. Native proteins were modified for a range of pI. Using radiolabeled proteins we showed that retention of proteins in cartilage is a function of their pI. At pI 8.5-9 all proteins showed a sharp increase in cartilage when incubated at physiologic pH. The molecular weight of a protein and its charge is a determining factor for penetration of cartilage. By autoradiography highly cationic proteins up to 150 kDa (IgG) readily penetrated cartilage. Immunofluorescence confirmed these findings. Cationic catalase (240 kDa) showed superficial penetration, but penetration of cationic ferritin (440 kDa) was not demonstrated, suggesting that 240 to 440 kDa represents the upper range for penetration. Small anionic proteins (cytochrome-c; pI less than 4.5; 12 kDa) penetrate in small quantities but do not persist, whereas larger anionic proteins (IgG; pI less than 4.5; 150 kDa) cannot penetrate at all. Our data help define the properties of proteins that are able to interact with cartilage matrix and chondrocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822925

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Degradation of cartilage proteoglycans by elastase is dependent on charge-mediated interactions.

Authors:  J Schalkwijk; L A Joosten; W B van den Berg; L B van de Putte
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

2.  Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.

Authors:  F A van de Loo; S Kuiper; F H van Enckevort; O J Arntz; W B van den Berg
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

Review 3.  Rheumatoid factors in immune complexes of patients with rheumatoid arthritis.

Authors:  M Mannik; F A Nardella; E H Sasso
Journal:  Springer Semin Immunopathol       Date:  1988

4.  Inhibition of proteoglycan synthesis by transforming growth factor beta in anatomically intact articular cartilage of murine patellae.

Authors:  P M van der Kraan; E L Vitters; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

5.  Action of polysaccharides of similar average mass but differing molecular volume and charge on fluid drainage through synovial interstitium in rabbit knees.

Authors:  D Scott; P J Coleman; R M Mason; J R Levick
Journal:  J Physiol       Date:  2000-11-01       Impact factor: 5.182

6.  Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study.

Authors:  W B van den Berg; F A van de Loo; W A Zwarts; I G Otterness
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

7.  In vivo role of phagocytic synovial lining cells in onset of experimental arthritis.

Authors:  P L Van Lent; A E Van den Hoek; L A Van den Bersselaar; M F Spanjaards; N Van Rooijen; C D Dijkstra; L B Van de Putte; W B Van den Berg
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

8.  Electrical charge of a protein determines penetration and localization in hyaline articular cartilage. Quantitative and autoradiographic studies on cartilage of different species, including man.

Authors:  P L van Lent; W B van den Berg; L B van de Putte; L van den Bersselaar
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

9.  A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro.

Authors:  H J Andrews; T A Plumpton; G P Harper; T E Cawston
Journal:  Agents Actions       Date:  1992-09

Review 10.  Long-Acting Growth Hormone Preparations - Current Status and Future Considerations.

Authors:  Bradley S Miller; Eric Velazquez; Kevin C J Yuen
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.